- Earth
Science Tech operates through diverse subsidiaries in the CBD space
- The
company offers a wide range of CBD products, as well as its MSN-2 medical
device
- ETST
has varied distribution agreements in place to strengthen its foothold in
the CBD marketplace
Earth Science Tech Inc. (OTCQB: ETST) is a
biotechnology company operating in varied and vibrant market sectors, including
hemp cannabidiol (CBD), nutraceuticals, pharmaceuticals and medical-device
research and development. Headquartered in Doral, Florida, the company
functions by way of diverse, wholly owned subsidiaries centered on developing
its role as a global leader in the CBD space. These subsidiaries are also
expanding Earth Science Tech’s work in the pharmaceutical and medical-device
sectors.
Earth Science Pharmaceutical Inc. is one of the company’s
subsidiaries. Its emphasis is on becoming a worldwide leader in the development
of low-cost, non-invasive diagnostic tools, medical devices, testing processes
and vaccines for STIs (sexually transmitted infections and/or diseases) (http://ibn.fm/lrECC). The first
medical device offered by Earth Science Pharmaceutical is the MSN-2 Chlamydia
Home Kit Screening, designed to detect STIs.
The company’s technology depends on the use of a modified
panty liner (MSN-2) worn for four hours to collect a sample of human cells. The
liner is then sent to a designated lab, where the cells are subsequently
analyzed employing a proven and established process. Modified panty liners have
less- strict transport criteria than urine or vaginal swabs. The company is
advancing clinical trials of MSN-2 via a collaborative agreement with
Laboratories BNK Canada (http://ibn.fm/wnCtn).
Another subsidiary of Earth Science Tech is Cannabis
Therapeutics Inc. Cannabis Therapeutics is committed to become a global leader
in cannabinoid research and development (R&D) for an extensive line of
cannabinoid-based pharmaceuticals, nutraceuticals and other products and
solutions. Its mission is to help change the health care landscape by
introducing proprietary products made for the global pharmaceutical- and
retail-consumer markets.
Cannabis Therapeutics has a provisional application patent
for CBD and is invested in R&D to explore and harness the medicinal power
of cannabidiol. The company is working to develop CBD-based drugs and
nutraceutical products and is also working to integrate CBD molecules with
existing generic drug molecules. Cannabis Therapeutics is concentrating on
developing pioneering products that provide treatment options for patients and
physicians.
Furthermore, Earth Science Tech has its Canna Inno
Laboratories Inc. subsidiary. Earth Science Tech established this subsidiary in
2017 to carve out a position in the Canadian province of Québec, giving ETST
inside access to the thriving Canadian CBD market. Canna Inno Laboratories
provides ETST with access to government grants offered to innovators in the
pharmaceutical industry; Canna Inno’s first grant has received approval (http://ibn.fm/veTzP).
Overall, Earth Science Tech offers its unique product lineup
in varied forms including liquids, tablets, capsules, soft gels, sprays,
chewables, creams, whole herbs and powders. The company’s product family
includes CBD oil for pets, flavored and infused CBD oils and a line of organic
chocolate CBD products. The company’s CBD oil is 100 percent natural and
organic and is manufactured using a supercritical CO2 liquid extraction
process.
Earth Science Tech also has key distribution agreements in
place to further the market reach of its products. This year, the company
signed agreements to distribute CBD products via pharmacies, chiropractors,
dispensaries, athletic clubs and clinics (http://ibn.fm/6OWnD). ETST is advancing product placement
in large chains, health-food stores and other establishments, and the
agreements are for the distribution of a high-grade, full-spectrum cannabinoid
line. Agreements are in place with CannaBiz and Desert Sun Distribution.
Moreover, Earth Science Tech has partnered with the
University of Central Oklahoma and DV Biologics Laboratory to work on projects
that scientifically support and advance the health care benefits of the
company’s high-grade, hemp-CBD oil.
Earth Science Tech continues to focus on the new frontier
involving the innovative integration of CBD with generic drug molecules. With a
management team that has decades of invaluable experience in the nutraceutical,
dietary supplement, and life sciences sectors, ETST offers investors an
attractive opportunity in the emerging CBD space. Earth Science Tech remains
dedicated to growing its product portfolio and customer base.
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates
relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
